Nordicus Partners Navigates Capital Shifts in Latest 10-K
Ticker: NORD · Form: 10-K · Filed: Jul 29, 2025 · CIK: 1011060
Sentiment: mixed
Topics: 10-K Filing, Management Consulting, Capital Structure, Related Party Transactions, Corporate Governance, SEC Filings, Financial Reporting
TL;DR
**NORD's capital structure is a moving target; proceed with caution until more financial specifics emerge.**
AI Summary
Nordicus Partners Corp (NORD) filed its 10-K for the fiscal year ended March 31, 2025, revealing a continued focus on its management consulting services. While specific revenue and net income figures are not detailed in the provided excerpt, the filing indicates changes in its capital structure, including the classification of Series A Junior Preferred Stock and undesignated Preferred Stock as of March 31, 2025. The company's historical name changes, from CARDIOTECH INTERNATIONAL INC in 1996 to EKIMAS Corp in 2020, highlight a shifting business strategy over decades. The report also details changes in common stock, additional paid-in capital, and retained earnings between March 31, 2023, and March 31, 2025, suggesting ongoing financial adjustments. The company's business address remains 280 South Beverly Dr., Suite 505, Beverly Hills, CA 90212, indicating operational stability despite financial shifts. The filing also notes related party transactions, which are a key area for investor scrutiny.
Why It Matters
Nordicus Partners' 10-K filing provides crucial insights into its financial health and strategic direction, particularly for investors monitoring its management consulting services. The detailed changes in common stock and preferred stock classifications, alongside related party transactions, can signal potential dilution or shifts in control, directly impacting shareholder value. In a competitive consulting landscape, understanding NORD's capital structure adjustments helps investors gauge its ability to fund growth and compete with larger, more established firms. Employees and customers may also be affected by the company's financial stability and strategic pivots, influencing job security and service continuity.
Risk Assessment
Risk Level: medium — The risk level is medium due to the lack of specific revenue and net income figures in the provided excerpt, making it difficult to assess operational performance. The presence of 'Related Party Member' transactions as of March 31, 2025, introduces potential conflicts of interest or non-arm's length dealings, which can be a significant risk for minority shareholders. Additionally, the historical name changes from CARDIOTECH INTERNATIONAL INC to EKIMAS Corp to Nordicus Partners Corp suggest a history of business model shifts, which can indicate instability or a lack of long-term strategic focus.
Analyst Insight
Investors should scrutinize the full 10-K for detailed financial statements, especially revenue, net income, and cash flow, to understand Nordicus Partners' operational performance. Pay close attention to the nature and value of related party transactions, as these can significantly impact profitability and governance. Consider the implications of the company's historical business changes on its current strategy and future growth prospects.
Key Numbers
- 2025-03-31 — Fiscal Year End Date (The period covered by this 10-K filing.)
- 0001011060 — Central Index Key (CIK) (Unique identifier for Nordicus Partners Corp with the SEC.)
- 1996-03-21 — Date of Name Change (When the company changed from CARDIOTECH INTERNATIONAL INC.)
- 2020-04-06 — Date of Name Change (When the company changed from EKIMAS Corp to Nordicus Partners Corp.)
Key Players & Entities
- Nordicus Partners Corp (company) — filer of the 10-K
- CARDIOTECH INTERNATIONAL INC (company) — former name of Nordicus Partners Corp until 1996
- AdvanSource Biomaterials Corp (company) — former name of Nordicus Partners Corp until 2008
- EKIMAS Corp (company) — former name of Nordicus Partners Corp until 2020
- SEC (regulator) — recipient of the 10-K filing
- 0001011060 (regulator) — Central Index Key (CIK) for Nordicus Partners Corp
- March 31, 2025 (date) — fiscal year end for the 10-K
- 280 South Beverly Dr., Suite 505, Beverly Hills, CA 90212 (location) — business address of Nordicus Partners Corp
FAQ
What is Nordicus Partners Corp's primary business according to the 10-K?
Nordicus Partners Corp's primary business is classified under SIC code 8742, which corresponds to Services-Management Consulting Services. This indicates their core operations involve providing advisory and consulting services to businesses.
When was Nordicus Partners Corp's fiscal year end for this 10-K filing?
Nordicus Partners Corp's fiscal year end for this 10-K filing was March 31, 2025. The report covers the period from April 1, 2024, to March 31, 2025.
What were the previous names of Nordicus Partners Corp?
Nordicus Partners Corp has undergone several name changes, previously being known as EKIMAS Corp (until April 6, 2020), AdvanSource Biomaterials Corp (until October 21, 2008), and CARDIOTECH INTERNATIONAL INC (until March 21, 1996).
Does the Nordicus Partners 10-K mention related party transactions?
Yes, the Nordicus Partners 10-K explicitly mentions 'us-gaap:RelatedPartyMember' as of March 31, 2025, indicating the presence of transactions with related parties. These transactions warrant further investigation for potential conflicts of interest.
What is the significance of Series A Junior Preferred Stock for Nordicus Partners?
The filing indicates the existence of 'NORD:SeriesAJuniorMember' preferred stock as of March 31, 2025, and March 31, 2024. This suggests a specific class of preferred equity with particular rights and preferences, which can impact common shareholders.
Where is Nordicus Partners Corp's business address located?
Nordicus Partners Corp's business address is 280 South Beverly Dr., Suite 505, Beverly Hills, CA 90212. Their business phone number is 508-523-3141.
What changes occurred in Nordicus Partners' common stock between 2023 and 2025?
The filing shows changes in 'us-gaap:CommonStockMember' from March 31, 2023, through the fiscal year ended March 31, 2025, indicating adjustments to the number of outstanding common shares or their par value over this period.
How does the SEC classify Nordicus Partners Corp?
The SEC classifies Nordicus Partners Corp under the Standard Industrial Classification (SIC) code 8742, which is for Services-Management Consulting Services. Their SEC file number is 001-11737.
What is the impact of 'us-gaap:AdditionalPaidInCapitalMember' changes on Nordicus Partners?
Changes in 'us-gaap:AdditionalPaidInCapitalMember' between March 31, 2023, and March 31, 2025, reflect capital raised from equity issuances above par value. This can indicate new investments or financing activities by Nordicus Partners.
What is the importance of the 'us-gaap:RetainedEarningsMember' in Nordicus Partners' filing?
The 'us-gaap:RetainedEarningsMember' figures from March 31, 2023, to March 31, 2025, show the cumulative net income or loss that Nordicus Partners has retained in the business. This is a key indicator of the company's profitability and ability to reinvest in itself.
Industry Context
Nordicus Partners Corp operates within the management consulting services sector (SIC 8742). This industry is characterized by a diverse range of firms, from large global consultancies to specialized boutique firms. Key trends include the increasing demand for digital transformation, data analytics, and strategic advisory services. Competition is often based on expertise, reputation, and client relationships.
Regulatory Implications
As a publicly traded entity, Nordicus Partners Corp is subject to SEC regulations and reporting requirements, including the timely filing of 10-K reports. Changes in accounting standards or disclosure requirements could impact financial reporting. The company must also ensure compliance with any industry-specific regulations relevant to its consulting services.
What Investors Should Do
- Analyze the nature and financial impact of related party transactions disclosed in the full 10-K.
- Investigate the specific drivers behind changes in common stock, additional paid-in capital, and retained earnings between FY2023 and FY2025.
- Seek further details on the classification and potential impact of Series A Junior Preferred Stock and undesignated Preferred Stock on the company's capital structure.
Key Dates
- 1996-03-21: Company Name Change from CARDIOTECH INTERNATIONAL INC — Indicates a significant shift in business focus or strategy from its original incorporation.
- 2008-10-21: Company Name Change from AdvanSource Biomaterials Corp — Further demonstrates a history of strategic pivots and rebranding efforts.
- 2020-04-06: Company Name Change from EKIMAS Corp to Nordicus Partners Corp — Marks the current corporate identity and likely a recent strategic direction.
- 2023-03-31: Previous Fiscal Year End — Provides a baseline for year-over-year financial comparisons.
- 2024-03-31: Prior Fiscal Year End — Serves as a comparison point for the current fiscal year's financial performance and structure.
- 2025-03-31: Current Fiscal Year End — The reporting date for the 10-K, reflecting the company's financial position and operational status.
Glossary
- Series A Junior Preferred Stock
- A class of preferred stock that ranks below other preferred stock and common stock in terms of liquidation preference and dividend rights. (Its classification in the capital structure as of March 31, 2025, impacts the company's equity composition and potential dilution for common shareholders.)
- Undesignated Preferred Stock
- Preferred stock that has not been assigned specific rights, preferences, or designations by the board of directors. (Indicates flexibility in the company's capital structure, allowing for future issuance with specific terms, and its presence affects the current equity structure.)
- Additional Paid-In Capital
- The amount of capital received by a company from its shareholders in exchange for stock that exceeds the par value of the stock. (Changes in this account between fiscal years reflect stock issuance activities or other equity transactions, impacting overall shareholder equity.)
- Retained Earnings
- The cumulative amount of net income that a company has retained over time, rather than distributing to shareholders as dividends. (Fluctuations in retained earnings indicate profitability and dividend payout policies, affecting the company's ability to reinvest in its business.)
- Related Party Transactions
- Financial transactions that occur between a company and its related parties, such as executives, major shareholders, or affiliated companies. (These transactions require careful scrutiny by investors due to the potential for conflicts of interest and non-market terms.)
- SIC Code 8742
- Standard Industrial Classification code for Management Consulting Services. (Confirms Nordicus Partners Corp's primary business activity as management consulting.)
Year-Over-Year Comparison
While specific financial performance metrics like revenue and net income are not detailed in this excerpt, the 10-K for the fiscal year ended March 31, 2025, indicates significant activity in the company's capital structure. Changes in common stock, additional paid-in capital, and retained earnings between March 31, 2023, and March 31, 2025, suggest ongoing financial adjustments. The classification of preferred stock also points to evolving equity arrangements compared to the prior fiscal year.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on July 29, 2025 regarding Nordicus Partners Corp (NORD).